HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic.

Abstract
This document, written by the French Association for the Study of the Liver (AFEF) board, aims to provide information to physicians involved in the care of patients with liver disease during the Coronavirus disease (COVID-19) epidemic. These are not based on a systematic review of the literature and a rigorous evaluation using the GRADE method. These are recommendations based on feedback from China available in the form of original articles or letters - for which the scientific evidence is often modest - and the rules put forward by American (1) and European (Boettler et al, 2020) hepatology societies, the French National Digestive Cancer Thesaurus (Di Fiore et al., 2020) and the Francophone Transplantation Society (4). These suggestions require adjustment according to the geographical particularities of the epidemic, available standard procedures and access to local resources. This document will be updated as regularly as possible according to the evolution of our knowledge and characteristics on the epidemic.
AuthorsNathalie Ganne-Carrié, Hélène Fontaine, Jérôme Dumortier, Jérôme Boursier, Christophe Bureau, Vincent Leroy, Marc Bourlière, AFEF, French Association for the Study of the Liver
JournalClinics and research in hepatology and gastroenterology (Clin Res Hepatol Gastroenterol) Vol. 44 Issue 3 Pg. 275-281 (06 2020) ISSN: 2210-741X [Electronic] France
PMID32360055 (Publication Type: Journal Article, Practice Guideline, Review)
CopyrightCopyright © 2020 Elsevier Masson SAS. All rights reserved.
Chemical References
  • Receptors, Virus
Topics
  • Ambulatory Care (organization & administration)
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections (epidemiology, prevention & control)
  • Employment
  • France
  • Hepatocytes (metabolism)
  • Hospitalization
  • Humans
  • Length of Stay
  • Liver (enzymology, virology)
  • Liver Diseases (classification, enzymology, therapy)
  • Pandemics (prevention & control)
  • Pneumonia, Viral (epidemiology, prevention & control)
  • Receptors, Virus (metabolism)
  • SARS-CoV-2
  • Societies, Medical
  • Time Factors
  • Transplant Recipients
  • Universal Precautions

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: